IBDEI0KB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9905,0)
 ;;=401.9^^58^645^63
 ;;^UTILITY(U,$J,358.3,9905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9905,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,9905,1,5,0)
 ;;=5^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,9905,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,9906,0)
 ;;=564.00^^58^645^38
 ;;^UTILITY(U,$J,358.3,9906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9906,1,4,0)
 ;;=4^564.00
 ;;^UTILITY(U,$J,358.3,9906,1,5,0)
 ;;=5^CONSTIPATION
 ;;^UTILITY(U,$J,358.3,9906,2)
 ;;=^323537
 ;;^UTILITY(U,$J,358.3,9907,0)
 ;;=600.00^^58^645^14
 ;;^UTILITY(U,$J,358.3,9907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9907,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,9907,1,5,0)
 ;;=5^BPH W/O URINARY OBSTRUCT
 ;;^UTILITY(U,$J,358.3,9907,2)
 ;;=^329932
 ;;^UTILITY(U,$J,358.3,9908,0)
 ;;=600.01^^58^645^13
 ;;^UTILITY(U,$J,358.3,9908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9908,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,9908,1,5,0)
 ;;=5^BPH W URINARY OBSTRUCTN
 ;;^UTILITY(U,$J,358.3,9908,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,9909,0)
 ;;=438.82^^58^645^50
 ;;^UTILITY(U,$J,358.3,9909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9909,1,4,0)
 ;;=4^438.82
 ;;^UTILITY(U,$J,358.3,9909,1,5,0)
 ;;=5^DYSPHAGIA,LATE EFF OF CVA
 ;;^UTILITY(U,$J,358.3,9909,2)
 ;;=^317923
 ;;^UTILITY(U,$J,358.3,9910,0)
 ;;=787.20^^58^645^49
 ;;^UTILITY(U,$J,358.3,9910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9910,1,4,0)
 ;;=4^787.20
 ;;^UTILITY(U,$J,358.3,9910,1,5,0)
 ;;=5^DYSPHAGIA NOS
 ;;^UTILITY(U,$J,358.3,9910,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,9911,0)
 ;;=787.29^^58^645^83
 ;;^UTILITY(U,$J,358.3,9911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9911,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,9911,1,5,0)
 ;;=5^OTHER DYSPHAGIA
 ;;^UTILITY(U,$J,358.3,9911,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,9912,0)
 ;;=199.1^^58^645^77
 ;;^UTILITY(U,$J,358.3,9912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9912,1,4,0)
 ;;=4^199.1
 ;;^UTILITY(U,$J,358.3,9912,1,5,0)
 ;;=5^METASTATIC CANCER
 ;;^UTILITY(U,$J,358.3,9912,2)
 ;;=^87705
 ;;^UTILITY(U,$J,358.3,9913,0)
 ;;=338.29^^58^645^33
 ;;^UTILITY(U,$J,358.3,9913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9913,1,4,0)
 ;;=4^338.29
 ;;^UTILITY(U,$J,358.3,9913,1,5,0)
 ;;=5^CHRONIC PAIN NEC
 ;;^UTILITY(U,$J,358.3,9913,2)
 ;;=^334077
 ;;^UTILITY(U,$J,358.3,9914,0)
 ;;=338.4^^58^645^34
 ;;^UTILITY(U,$J,358.3,9914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9914,1,4,0)
 ;;=4^338.4
 ;;^UTILITY(U,$J,358.3,9914,1,5,0)
 ;;=5^CHRONIC PAIN SYNDROME
 ;;^UTILITY(U,$J,358.3,9914,2)
 ;;=^334079
 ;;^UTILITY(U,$J,358.3,9915,0)
 ;;=585.1^^58^645^29
 ;;^UTILITY(U,$J,358.3,9915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9915,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,9915,1,5,0)
 ;;=5^CHRO KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,9915,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,9916,0)
 ;;=585.2^^58^645^30
 ;;^UTILITY(U,$J,358.3,9916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9916,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,9916,1,5,0)
 ;;=5^CHRO KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,9916,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,9917,0)
 ;;=585.3^^58^645^27
 ;;^UTILITY(U,$J,358.3,9917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9917,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,9917,1,5,0)
 ;;=5^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,9917,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,9918,0)
 ;;=585.4^^58^645^28
 ;;^UTILITY(U,$J,358.3,9918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9918,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,9918,1,5,0)
 ;;=5^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,9918,2)
 ;;=^332810
